{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:47:22Z","timestamp":1782895642535,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.acuroe.2026.501980","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:39:11Z","timestamp":1775057951000},"page":"501980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of mirabegron, tamsulosin, and tadalafil on quality of life in patients with indwelling ureteral (double-J) stents"],"prefix":"10.1016","volume":"50","author":[{"given":"A.","family":"Mahmoud Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Abdellah Ali Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Reyad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ali Abdelhaleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8919-0036","authenticated-orcid":false,"given":"T.","family":"Ahmed Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2026.501980_bib0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0094-0143(03)00091-0","article-title":"Stenting after ureteroscopy: pros and cons","volume":"31","author":"Knudsen","year":"2004","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.acuroe.2026.501980_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/and.12746","article-title":"Ureterorenoscopy with stenting and its effect on male sexual function: a controlled randomized prospective study","volume":"49","author":"Bolat","year":"2017","journal-title":"Andrologia"},{"key":"10.1016\/j.acuroe.2026.501980_bib0015","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/01.ju.0000048980.33855.90","article-title":"Indwelling ureteral stents: evaluation of symptoms, quality of life, and utility","volume":"169","author":"Joshi","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2026.501980_bib0020","first-page":"1","article-title":"Effectiveness of medical treatment in overcoming the ureteral double-J stent-related symptoms","volume":"6","author":"Kuyumcuoglu","year":"2011","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.acuroe.2026.501980_bib0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00240-009-0182-8","article-title":"Effects of specific alpha-1A\/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study","volume":"37","author":"Wang","year":"2009","journal-title":"Urol Res"},{"key":"10.1016\/j.acuroe.2026.501980_bib0030","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s11255-017-1667-y","article-title":"Expression of \u03b2-adrenergic receptor subtypes in human normal and dilated ureter","volume":"49","author":"Shen","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.acuroe.2026.501980_bib0035","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1089\/end.2012.0235","article-title":"Cross-cultural application of the Korean version of the Ureteral Stent Symptoms Questionnaire","volume":"26","author":"Park","year":"2012","journal-title":"J Endourol"},{"key":"10.1016\/j.acuroe.2026.501980_bib0040","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00120-007-1409-3","article-title":"PDE5 inhibitors: a new option in the treatment of ureteral colic?","volume":"46","author":"Gratzke","year":"2007","journal-title":"Urologe A"},{"issue":"4","key":"10.1016\/j.acuroe.2026.501980_bib0045","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.aju.2014.08.001","article-title":"Validation of the Arabic linguistic version of the Ureteral Stent Symptoms Questionnaire","volume":"12","author":"El-Nahas","year":"2014","journal-title":"Arab J Urol"},{"key":"10.1016\/j.acuroe.2026.501980_bib0050","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0090-4295(01)01644-2","article-title":"Characterization of urinary symptoms in patients with ureteral stents","volume":"59","author":"Joshi","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.acuroe.2026.501980_bib0055","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1464-410X.2011.10170.x","article-title":"Meta-analysis showing the beneficial effect of alpha-blockers on ureteric stent discomfort","volume":"108","author":"Lamb","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.acuroe.2026.501980_bib0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00240-009-0182-8","article-title":"Effects of specific alpha-1A\/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study","volume":"37","author":"Wang","year":"2009","journal-title":"Urol Res"},{"key":"10.1016\/j.acuroe.2026.501980_bib0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.urology.2013.08.067","article-title":"Role of alpha-blockers in the treatment of stent-related symptoms: a prospective randomized control study","volume":"83","author":"Dellis","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.acuroe.2026.501980_bib0070","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s11255-014-0825-8","article-title":"Efficacy of tamsulosin hydrochloride in relieving \u201cdouble-J ureteral stent-related morbidity\u201d: a randomized placebo controlled clinical study","volume":"46","author":"Singh","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.acuroe.2026.501980_bib0075","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.juro.2008.09.026","article-title":"Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study","volume":"181","author":"Beddingfield","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2026.501980_bib0080","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1089\/end.2014.0715","article-title":"Effects of alpha-Blockers, Antimuscarinics, or Combination Therapy in Relieving Ureteral Stent-Related Symptoms: A Meta-Analysis","volume":"29","author":"Zhou","year":"2015","journal-title":"J Endourol"},{"key":"10.1016\/j.acuroe.2026.501980_bib0085","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00240-013-0554-y","article-title":"Solifenacin improves double-J stent-related symptoms in both genders following uncomplicated ureteroscopic lithotripsy","volume":"41","author":"Lee","year":"2013","journal-title":"Urolithiasis"},{"key":"10.1016\/j.acuroe.2026.501980_bib0090","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2147\/DDDT.S99330","article-title":"Comparative efficacy of tamsulosin versus nifedipine for distal ureteral calculi: a meta-analysis","volume":"10","author":"Wang","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.acuroe.2026.501980_bib0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/17425250902762866","article-title":"Solifenacin succinate for the treatment of overactive bladder","volume":"5","author":"Hoffstetter","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.acuroe.2026.501980_bib0100","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/ijcp.12433","article-title":"Safety and tolerability of the beta3 -adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomized Phase III trials and a 1-year randomized Phase III trial","volume":"68","author":"Nitti","year":"2014","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.acuroe.2026.501980_bib0105","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.eururo.2012.10.016","article-title":"Efficacy and tolerability of mirabegron, a beta (3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial","volume":"63","author":"Khullar","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2026.501980_bib0110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/nau.20097","article-title":"Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter","volume":"24","author":"Sigala","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.acuroe.2026.501980_bib0115","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s11255-017-1667-y","article-title":"Expression of beta-adrenergic receptor subtypes in human normal and dilated ureter","volume":"49","author":"Shen","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.acuroe.2026.501980_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-9056(15)61068-5","article-title":"Does tadalafil alleviate ureteral stent related symptoms? A randomized controlled trial","volume":"14","author":"Hajebrahimi","year":"2015","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.acuroe.2026.501980_bib0125","first-page":"1009","article-title":"Efficacy and safety of solifenacin in patients with ureteral stent-related symptoms: a meta-analysis","volume":"38","author":"Zhang","year":"2020","journal-title":"World J Urol"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626000867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626000867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:14:23Z","timestamp":1782893663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578626000867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2173578626000867"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501980","relation":{},"ISSN":["2173-5786"],"issn-type":[{"value":"2173-5786","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of mirabegron, tamsulosin, and tadalafil on quality of life in patients with indwelling ureteral (double-J) stents","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501980","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2026.501980","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501980"}}